Study Compares Xolair to Oral Immunotherapy in Treating Food Allergies
Xolair was superior to oral immunotherapy in both effectiveness and fewer side effects for people with one or more food allergies.
Tag: Roche Pharma
All
Latest
Study Compares Xolair to Oral Immunotherapy in Treating Food Allergies
Xolair was superior to oral immunotherapy in both effectiveness and fewer side effects for people with one or more food allergies.
Read More
Oral Antiviral Xofluza Reduces Flu Transmission in Households
A phase III study demonstrated that a single oral dose of Xofluza significantly reduced the spread of influenza within households.
Read More
FDA Clears Roche Digital Pathology Diagnostic
The Roche Digital Pathology Dx whole slide imaging system is intended to assist pathologists in reviewing and interpreting digital images of scanned pathology slides to aid diagnose.
Read More
FDA Authorizes Roche 4-in-1 Test for SARS-CoV-2, Influenza A/B, RSV
The FDA issued emergency use authorization to Roche’s cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test, the company reports.
Read More
FDA Approves Genentech’s Alecensa for Early-Stage ALK-Positive NSCLC
Genentech says the approval makes the drug the first ALK inhibitor for patients with ALK-positive, early-stage non-small cell lung cancer who have undergone surgery.
Read More
Roche to Distribute Sepsis ImmunoScore from Prenosis
Roche will commercially distribute Prenosis Inc’s Sepsis ImmunoScore, the first-ever FDA De Novo authorized AI diagnostic tool for sepsis.
Read More
Omalizumab Reduces Allergic Reactions to Multiple Foods in Youth
The monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume.
Read More
A Discussion of Arterial Blood Gas Analysis and Interpretation
Arterial blood gases (ABGs) provide valuable information to help inform patient care decisions and for monitoring whether treatment is bringing about desired outcomes.
Read More
Lung Cancer: Lumakras Cuts Risk by 34%
Amgen’s Lumakras pill reduced the risk of disease progression in patients with advanced lung cancer by 34% compared with chemotherapy in a clinical trial.
Read More
AI-powered Lung Cancer Diagnosis
Roche and EarlySign have expanded their partnership to include AI-powered lung cancer diagnosis.
Read More
Roche App: Learning Your ABGs
Roche Diagnostics has released a new mobile app to help clinicians learn more about arterial blood gas measurements.
Read MoreRoche Pulls Out of ‘Superbug’ Antibiotic Project
Swiss drugmaker Roche has dropped out of a high-profile project to develop an antibiotic for treating “superbug” infections, including P. aeruginosa.
Read More
The Newest Generation of Blood Gas Analyzers
The latest advancements in blood gas analysis technology are focused on fast, reliable, point-of-care solutions that improve diagnosis times for patients and clinicians.
Read More
Blood Gas Analysis Products
A closer look at blood gas analysis products on the market.
Read More
Blood Gas Analysis Products
A look at blood gas analysis products.
Read More
FDA Clears pH Testing on Roche Omni Blood Gas Analyzer
Roche Diagnostics has received FDA clearance for measuring pH in pleural fluid samples on the Roche OMNI blood gas analyzers.
Read More
Industry Analysis: Roche Diagnostics
RT interviewed Lynda Koestner of Roche Diagnostics Corp about the essential diagnostic equipment needed to treat respiratory problems.
Read More